Related Experiment Videos
Data management solutions for protein therapeutic research and development.
Jost Vielmetter1, Jeff Tishler, Marie L Ary
1Xencor, 111 W. Lemon Avenue, Monrovia, CA 91016, USA. jvielmet@xencor.com
Drug Discovery Today
|August 2, 2005
Summary
Researchers adapted a small-molecule screening system for protein therapeutics discovery. This integration links protein variants with assay data, improving drug development and decision-making for R&D.
Area of Science:
- Biotechnology
- Drug Discovery
- Computational Biology
Background:
- Protein therapeutics, such as monoclonal antibodies, are increasingly vital in drug discovery.
- High-throughput screening (HTS) of extensive protein variant libraries is crucial for R&D.
- A gap exists in linking variant protein sequences with chemical and biological assay data for efficient analysis.
Purpose of the Study:
- To adapt a small-molecule HTS data management system for protein drug discovery.
- To facilitate the integration of protein variant sequences with assay data.
- To enhance data mining and decision-making in hit identification, lead optimization, and drug development.
Main Methods:
- Implementation of a data management system.
- Adaptation of a small-molecule HTS system for protein-based research.
- Integration of protein sequence data with assay results.
Main Results:
- A functional system for managing protein variant screening data was developed.
- The adapted system enables efficient linking of protein sequences to assay data.
- Improved data integration supports streamlined R&D processes.
Conclusions:
- The adapted system effectively addresses the data management needs of protein drug discovery.
- This integration enhances efficiency in analyzing large-scale protein screening data.
- The approach facilitates better decision-making throughout the drug development pipeline.